
Global Health (MEDANTA) Share Price Falls 2.04% as Medanta Trades at Rs 1,207.40
Updated: 22 Oct 2026 • 10:57 am
Posted by:

Global Health Share Price is under pressure today, with Medanta trading at Rs 1,207.40, down 2.04% from the previous close of Rs 1,232.55. The company’s market capitalisation stands at Rs 33,277.29 crore, which places it in the Large Cap category. According to latest Univest data, the move is a clear price fall in an active healthcare stock, and the opening trade range gives a useful snapshot of how the day has unfolded so far. The stock opened at Rs 1,226.40, touched a high of Rs 1,226.40 and a low of Rs 1,203.70, so the latest Global Health Share Price is trading near the lower end of the day’s range. For readers tracking Global Health Stock News, the immediate focus is on price action, valuation and sector comparison rather than any unsupported catalyst.
Univest data confirms the move itself, though no company-specific trigger has been identified. That makes the current Global Health Share Price relevant as a clean market move: the stock is lower, the day range is defined, and the market cap remains substantial for a Large Cap healthcare name. In today’s Global Health Share Price Today update, the question is not only why the stock is falling today, but also what the valuation and operating metrics say about the context around Medanta Share Price. Univest data helps frame the move without inventing a reason, and the next sections look at price action, fundamentals, sector benchmarks and peers in a structured way.
Global Health (MEDANTA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,207.4 |
| Previous Close | Rs 1,232.55 |
| Today's Move | -Rs 25.15 (-2.04%) |
| Open | Rs 1,226.4 |
| High | Rs 1,226.4 |
| Low | Rs 1,203.7 |
| Market Capitalisation | Rs 33,277.29 crore |
| Market Cap Category | Large Cap |
The current Global Health Share Price is Rs 1,207.40 versus a previous close of Rs 1,232.55, which translates into a decline of Rs 25.15 or 2.04%. The stock opened at Rs 1,226.40, matched that as the day high, and then moved down to Rs 1,203.70 at the day low. That places the latest Global Health Share Price closer to the lower band of the intraday range than to the opening level. The market capitalisation of Rs 33,277.29 crore shows that Medanta remains a Large Cap company, so today’s move is a share price fall in a well-established listed healthcare business rather than a small-price swing in a thinly valued name. For readers checking Global Health Share Price Live updates, the data points describe a clear decline without adding any extra story beyond the numbers. The next step is to see whether the fundamental profile gives this Global Health Share Price move additional context.
Global Health (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,277.29 crore |
| P/E Ratio | 59.59x |
| P/B Ratio | 8.06x |
| ROE | 15.12% |
| ROCE | 19.38% |
| EPS | Rs 20.69 |
| Book Value Per Share | Rs 152.94 |
| Dividend Yield | 0.04% |
Global Health (MEDANTA) fundamental metrics show P/E 59.59x, P/B 8.06x, ROE 15.12%, ROCE 19.38%. Read together, these ratios describe the company's position rather than a recommendation.
Global Health has a market capitalisation of Rs 33,277.29 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 59.59x, P/B at 8.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.94, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 42.03x, median ROE of 13.07%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 59.59x |
| Benchmark Median P/E | 42.03x |
| Benchmark Average P/E | 92.56x |
| Benchmark P/E Range | 6.48x to 1,528.53x |
| Company P/B Ratio | 8.06x |
| Benchmark Median P/B | 3.67x |
| Benchmark Average P/B | 3.9x |
| Company ROE | 15.12% |
| Benchmark Median ROE | 13.07% |
| Benchmark Average ROE | 10.69% |
| Company ROCE | 19.38% |
| Benchmark Median ROCE | 15.83% |
| Benchmark Average ROCE | 1.93% |
| Company Market Capitalisation | Rs 33,277.29 crore |
| Benchmark Median Market Cap | Rs 532.26 crore |
| Benchmark Average Market Cap | Rs 9,854.74 crore |
Global Health (MEDANTA) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.
Global Health (MEDANTA) has a P/E ratio of 59.59x, which is above the benchmark median of 42.03x, a difference of +41.78%. The P/E comparison frames valuation; it is not a signal to buy or sell.
Global Health (MEDANTA) has a ROE of 15.12%, which is above the benchmark median of 13.07%, a difference of +15.68%. Global Health (MEDANTA) has a ROCE of 19.38%, which is above the benchmark median of 15.83%, a difference of +22.43%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,10,757.32 | 52.33 | 11.29 | 23.54 | 21.73 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 82,855.61 | 92.4 | 4.97 | 12.95 | 13.93 |
| Max Healthcare Institute | MAXHEALTH | 80,716.62 | 54.78 | 7.3 | 14.53 | 14.97 |
| Aster DM Healthcare | ASTERDM | 58,157.99 | 177.79 | 13.4 | 13.07 | 16.22 |
| Fortis Healthcare | FORTIS | 55,553.6 | 52.45 | 5.41 | 11.32 | 14.07 |
Global Health (MEDANTA) has a P/E ratio of 59.59x compared with the displayed peer median of 54.78x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 15.12% compares with a peer median of 13.07% across the companies shown in the table. ROCE stood at 19.38% versus the displayed peer median of 14.97%, providing a capital-efficiency comparison. Global Health (MEDANTA) has a market capitalisation of Rs 33,277.29 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Global Health
- Global Health Share Price is down 2.04% today, with the stock trading at Rs 1,207.40 versus the previous close of Rs 1,232.55.
- The day range of Rs 1,203.70 to Rs 1,226.40 shows the Global Health Share Price is trading near the lower end of the intraday band.
- Market capitalisation of Rs 33,277.29 crore keeps Medanta in the Large Cap category and relevant in healthcare market updates.
- Global Health Fundamental Analysis shows ROE of 15.12%, ROCE of 19.38%, EPS of Rs 20.69 and book value of Rs 152.94.
- Peer comparison places Global Health Share Price above the industry median valuation, with stronger returns than the same-industry median.
About Global Health
Global Health operates in the Healthcare sector and the Hospital & Healthcare Services industry. The business is associated with hospital-led healthcare delivery, which places the company in a segment where pricing, service mix and operating returns matter closely. Medanta’s listed profile makes it part of the broader Indian healthcare universe, where investors compare valuation, profitability and market capitalisation across major hospital chains and diagnostic names. In today’s Global Health Share Price news context, the company stands out as a Large Cap healthcare name with a meaningful market presence and return ratios that remain above the industry median.
Track Global Health Share Price on Univest
Use Global Health (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Global Health Share Price on Univest for live price updates, key ratios, market capitalisation, 52-week levels and stock news in one place. Medanta investors can also review Global Health Fundamental Analysis, sector benchmarks and peer context on the same page. Univest keeps the Global Health Share Price view organised for quick monitoring during market hours.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Global Health Share Price falling today?
Ans. Global Health Share Price is lower by 2.04% today and is trading at Rs 1,207.40 versus the previous close of Rs 1,232.55. Univest data confirms the move itself, though no company-specific trigger has been identified.
What is the current Global Health Share Price today?
Ans. The current Global Health Share Price is Rs 1,207.40. It opened at Rs 1,226.40, touched a high of Rs 1,226.40 and a low of Rs 1,203.70, so the stock is trading near the lower end of its intraday range.
How much did Medanta fall today?
Ans. Medanta fell Rs 25.15 today, which equals a 2.04% decline from the previous close. That move takes the Global Health Share Price from Rs 1,232.55 to Rs 1,207.40 in early trade.
What is Global Health market capitalisation?
Ans. Global Health has a market capitalisation of Rs 33,277.29 crore. That places the company in the Large Cap category and gives context to the current Global Health Share Price movement within the healthcare space.
What does Global Health Fundamental Analysis show?
Ans. Global Health Fundamental Analysis shows a P/E of 59.59, P/B of 8.06, ROE of 15.12%, ROCE of 19.38%, EPS of Rs 20.69 and book value of Rs 152.94. Dividend yield is 0.04%.
How does Global Health compare with healthcare peers?
Ans. Global Health Share Price is linked to a company whose P/E is above the industry median of 42.03, while ROE and ROCE are above the same-industry medians. Apollo, Max Healthcare and Fortis provide useful peer context.
Is Global Health valued above the healthcare benchmark?
Ans. Yes. Global Health trades at 59.59 times earnings, above the same-industry median P/E of 42.03 and above the same-industry median P/B of 3.67. The valuation sits at a premium to the benchmark set.
What is the meaning of EPS and book value for Medanta?
Ans. EPS of Rs 20.69 shows earnings attributable to each share, while book value of Rs 152.94 shows the accounting net worth behind each share. Both are useful anchors when assessing Global Health Share Price and valuation.
Should investors track Global Health Share Price on Univest?
Ans. Yes, readers can track Global Health Share Price on Univest for live updates, valuation ratios, 52-week levels and market insights. That helps place each new move alongside the company’s fundamental and sector context.
Recent Articles

Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
23 October 2026

Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
23 October 2026

Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
23 October 2026

Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
23 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Infosys Dividend 2026: Rs 26 Per Share Interim Payout, Record Date, Q2 Profit Up 6.23% and What Shareholders Should Know
Ambit Capital Telecom Picks: Why the Brokerage Backs Airtel, Vodafone Idea and Indus Towers With Buy Ratings and Higher Targets
Delhi Pollution Curbs: Can They Be a Game-Changer for Auto and EV Stocks From Ather Energy to TMPV?
Swiggy vs Eternal Shares Compared: Which Is the Better Stock After Q2 FY27 Results as Blinkit Profit Meets Instamart Loss?
Himadri Speciality Share Price Posts Its Biggest Weekly Fall Since 2008: What Q2 FY27 Margins, Valuation and Guidance Say
Popular this week
Smallcap Stocks Falling Today: Why Mid and Small-Caps Are Bleeding as Swiggy, Meesho, Vedanta Aluminium and MCX Lose Big

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





